S
LIVE

Serial Number

97812999

Owner

DEKA Research & Development Corp.

Attorney

Mark E. Tetreault

Filing Date

Feb 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

S Trademark

Serial Number: 97812999

S is a trademark filed by DEKA Research & Development Corp. on February 27, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

DEKA Research & Development Corp. (30 trademarks)

340 Commercial Street
Manchester, NH 03101

Entity Type: 03

Trademark Details

Filing Date

February 27, 2023

Registration Date

Not Registered

Published for Opposition

February 27, 2024

Goods & Services

Software as a Medical Device (SaMD), downloadable, for predicting blood analyte levels and adjusting infusion pump settings based on personalized data; Downloadable educational mobile applications featuring information and instruction on managing, treating and living with chronic disease; batteries; battery chargers

Software-as-a-service (SAAS) featuring software for use in the acquisition, capture, processing, presentation, transmission and storage of medical and physiological data obtained from medical sensors that are implanted or inserted into the human body; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports relating to managing chronic disease, medication and analyte levels; Upgrading of computer software, namely, Software as a Medical Device (SaMD)

Interactive medical monitoring and alert services for reminding infusion pump users of medicinal dosage for medical treatment purposes in the nature of monitoring and managing chronic disease; Providing medical information to infusion pump users in the form of reports in the field of chronic disease management; Providing a website featuring general medical information related to chronic diseases, including advice on treatment options and chronic disease management; providing online searchable medical databases in the field of chronic disease management for patients. their families and caregivers, and healthcare practitioners; medical consultation services, namely, patient ambassador program to communicate medical information to people with chronic disease

Providing a trade-in program for drug delivery and chronic disease management devices; Pharmaceutical services, namely, mail order pharmacy services and processing online and telephone prescription orders in retail and central fill pharmacies featuring chronic disease management supplies, medications, drugs and other prescriptions

Medical devices, namely, infusion and injection devices for administering drugs, and pouches and mounts used therewith; medical devices, namely, infusion pumps for delivering measured amounts of solutions into the bloodstream over time; medical apparatus for monitoring blood analyte levels; implantable subcutaneous drug delivery devices, sold empty, in the nature of medical fluid injectors; on-body medical fluid injectors; chronic disease management devices in the nature of medical sensors that are implanted or inserted into the human body used to continuously gather human biometric data for monitoring the concentration of analytes in the human body and also including accessories therefor, namely, receivers, sensor housings and sensor insertion devices sold as a unit; medical infusion sets comprised of infusion tubing, infusion needles, needle guards, connectors, attachment clips, and accessories therefor

Educational services, namely, creating and developing web-based and in person classes, seminars, workshops and programs in the field of managing and living with chronic disease; personalized training and coaching in the use of monitoring devices and infusion pumps in the treatment of chronic disease; training of healthcare providers in chronic disease treatment and the use of infusion pumps and infusion sets

Infusion cartridges sold pre-filled with medication for medical use in the field of cardiovascular disease, diabetes, asthma, kidney disease, and cancer; Adhesive overlays in the nature of adhesive medical tape and adhesive bandages for use with infusion pumps and associated devices

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 22, 2026 EXRA
SOU EXTENSION 4 GRANTED
Apr 21, 2026 EX4G
SOU EXTENSION 4 FILED
Apr 21, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 21, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 21, 2025 EXRA
SOU EXTENSION 3 GRANTED
Oct 20, 2025 EX3G
SOU EXTENSION 3 FILED
Oct 20, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 20, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 16, 2025 EXRA
SOU EXTENSION 2 GRANTED
Apr 15, 2025 EX2G
SOU EXTENSION 2 FILED
Apr 15, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 15, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 8, 2024 EXRA
SOU EXTENSION 1 GRANTED
Oct 8, 2024 EX1G
SOU EXTENSION 1 FILED
Oct 8, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 8, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 23, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 4, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 27, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 7, 2024 NONP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 7, 2024 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 24, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 24, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 24, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 24, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 24, 2024 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 24, 2024 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Dec 19, 2023 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 5, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 30, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 30, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 30, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 29, 2023 GNRN
NON-FINAL ACTION E-MAILED
Nov 29, 2023 GNRT
NON-FINAL ACTION WRITTEN
Nov 29, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 28, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Mar 17, 2023 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 16, 2023 NWOS
NEW APPLICATION ENTERED
Mar 2, 2023 NWAP